{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:05:47Z","timestamp":1791187547557,"version":"4.1.0"},"reference-count":107,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPD"],"published-print":{"date-parts":[[2015,9,14]]},"DOI":"10.3233\/jpd-150535","type":"journal-article","created":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T14:27:57Z","timestamp":1442240877000},"page":"625-636","source":"Crossref","is-referenced-by-count":86,"title":["Apathy and Impulse Control Disorders: Yin\u00a0&amp; Yang of Dopamine Dependent Behaviors"],"prefix":"10.1177","volume":"5","author":[{"given":"Mar\u00eda","family":"Sierra","sequence":"first","affiliation":[{"name":"Service of Neurology, University Hospital \u201cMarqu\u00e9s de Valdecilla (IFIMAV)\u201d, University of Cantabria and \u201cCentro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Neurodegenerativas (CIBERNED)\u201d, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Carnicella","sequence":"additional","affiliation":[{"name":"INSERM, Unit 836, Grenoble Institut des Neurosciences, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio P.","family":"Strafella","sequence":"additional","affiliation":[{"name":"Morton and Gloria Shulman Movement Disorder Unit - E.J. Safra Parkinson Disease Program, Toronto Western Hospital and Research Institute, UHN & Research Imaging Centre, Campbell Family Mental Health Research Institute, CAMH, University of Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Bichon","sequence":"additional","affiliation":[{"name":"Movement Disorder Unit, Department of Psychiatry and Neurology, CHU de Grenoble, Joseph Fourier University, Grenoble Universit\u00e9s, France; and INSERM, Unit 836, Grenoble Institut des Neurosciences, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e9nie","family":"Lhomm\u00e9e","sequence":"additional","affiliation":[{"name":"Movement Disorder Unit, Department of Psychiatry and Neurology, CHU de Grenoble, Joseph Fourier University, Grenoble Universit\u00e9s, France; and INSERM, Unit 836, Grenoble Institut des Neurosciences, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Castrioto","sequence":"additional","affiliation":[{"name":"Movement Disorder Unit, Department of Psychiatry and Neurology, CHU de Grenoble, Joseph Fourier University, Grenoble Universit\u00e9s, France; and INSERM, Unit 836, Grenoble Institut des Neurosciences, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Chabardes","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery CHU de Grenoble, Joseph Fourier University, Grenoble, France and INSERM, Unit\u00e9 836, Grenoble Institut des Neurosciences, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Thobois","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lyon, F-69622, Lyon, France; Universit\u00e9 Lyon 1, Villeurbanne, France; CNRS, UMR5229, Centre de Neuroscience Cognitive, Bron, France; H\u00f4pital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Krack","sequence":"additional","affiliation":[{"name":"Movement Disorder Unit, Department of Psychiatry and Neurology, CHU de Grenoble, Joseph Fourier University, Grenoble Universit\u00e9s, France; and INSERM, Unit 836, Grenoble Institut des Neurosciences, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JPD-150535_ref1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1176\/jnp.3.3.243","article-title":"Apathy: A\u00a0neuropsychiatric syndrome","volume":"3","author":"Marin","year":"1991","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.3233\/JPD-150535_ref2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/cercor\/bhj043","article-title":"Apathy and the functional anatomy ofthe prefrontal cortex-basal ganglia circuits","volume":"16","author":"Levy","year":"2006","journal-title":"Cereb Cortex"},{"key":"10.3233\/JPD-150535_ref3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1474-4422(15)00019-8","article-title":"Apathyin Parkinson\u2019s disease: clinical features, neural substrates,diagnosis, and treatment","volume":"14","author":"Pagonabarraga","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-150535_ref4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eurpsy.2008.09.001","article-title":"Proposed diagnostic criteria for apathy in Alzheimer\u2019s disease and other neuropsychiatric disorders","volume":"24","author":"Robert","year":"2009","journal-title":"Eur Psychiatry"},{"key":"10.3233\/JPD-150535_ref5","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/mds.23268","article-title":"Neuroanatomical correlates of apathy in Parkinson\u2019s disease: A\u00a0magnetic resonance imaging study using voxel-based morphometry","volume":"25","author":"Reijnders","year":"2010","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrneurol.2011.21","article-title":"White matter lesions in Parkinson disease","volume":"7","author":"Bohnen","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JPD-150535_ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-9338(13)76659-8","article-title":"Prevalence of apathy and depression in a population of elderly subjects using especific diagnostic criteria: Preliminary results from a multicenter cross-sectional study (ADEP study)","volume":"28","author":"Bensamoun","year":"2013","journal-title":"Eur Psychiatr"},{"key":"10.3233\/JPD-150535_ref8","unstructured":"E. B. Vingt-troisi\u00e8me le\u00e7on, nature et pathog\u00e9nie de la maladie de Parkinson, Paris: Masson."},{"key":"10.3233\/JPD-150535_ref9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","article-title":"Prediagnostic presentations of Parkinson\u2019s disease in primarycare: A\u00a0case-control study","volume":"14","author":"Schrag","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-150535_ref10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/mds.870070203","article-title":"When did Ray Kennedy\u2019s Parkinson\u2019s disease begin?","volume":"7","author":"Lees","year":"1992","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref11","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/mds.22589","article-title":"Neuropsychiatric symptomsin Parkinson\u2019s disease","volume":"24","author":"Aarsland","year":"2009","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref12","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/mds.25584","article-title":"Assessing apathy in everyday clinical practice with theshort-form Lille Apathy Rating Scale","volume":"28","author":"Dujardin","year":"2013","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref13","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00415-014-7498-1","article-title":"Apathy in untreated,patients with Parkinson\u2019s disease: Validation study of ApathyEvaluation Scale","volume":"261","author":"Santangelo","year":"2014","journal-title":"J Neurol"},{"key":"10.3233\/JPD-150535_ref14","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: A\u00a0multicenter assessment of nonmotor symptoms and theirimpact on quality of life in Parkinson\u2019s disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/jnnp-2012-303419","article-title":"Non-motor symptoms in early Parkinson\u2019s disease: A\u00a02-year follow-up study on previously untreated patients","volume":"84","author":"Erro","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-150535_ref16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1212\/WNL.43.8.1459","article-title":"The spectrum of levodopa-related fluctuations in Parkinson\u2019s disease","volume":"43","author":"Riley","year":"1993","journal-title":"Neurology"},{"key":"10.3233\/JPD-150535_ref17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: Diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.3233\/JPD-150535_ref18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.26121","article-title":"Behavioral effects of levodopa","volume":"30","author":"Beaulieu-Boire","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.parkreldis.2013.02.018","article-title":"Rotigotine and specific non-motor symptoms of Parkinson\u2019s disease:analysis of RECOVER","volume":"19","author":"Ray Chaudhuri","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-150535_ref20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.3233\/JPD-150535_ref21","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa035275","article-title":"Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson\u2019s disease","volume":"349","author":"Krack","year":"2003","journal-title":"N Engl J Med"},{"key":"10.3233\/JPD-150535_ref22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/brain\/awq032","article-title":"Non-motor dopamine withdrawal syndrome after surgery for Parkinson\u2019s disease: Predictors and underlying mesolimbic denervation","volume":"133","author":"Thobois","year":"2010","journal-title":"Brain"},{"key":"10.3233\/JPD-150535_ref23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneurol.2009.294","article-title":"Dopamine agonist withdrawalsyndrome in Parkinson disease","volume":"67","author":"Rabinak","year":"2010","journal-title":"Arch Neurol"},{"key":"10.3233\/JPD-150535_ref24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mds.10441","article-title":"Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson\u2019s disease","volume":"18","author":"Funkiewiez","year":"2003","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jnnp-2012-302444","article-title":"Psychostimulant effect of levodopa: Reversing sensitisation is possible","volume":"84","author":"Castrioto","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-150535_ref26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1474-4422(13)70294-1","article-title":"Mood andbehoural effects of subthalamic stimulation in Parkinson\u2019s disease","volume":"13","author":"Castrioto","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-150535_ref27","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/WNL.0b013e3181c34b34","article-title":"Subthalamic nucleus stimulation inParkinson disease induces apathy: A\u00a0PET study","volume":"73","author":"Le Jeune","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JPD-150535_ref28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mds.21949","article-title":"Apathy following subthalamic stimulation in Parkinson disease: A\u00a0dopamine responsive symptom","volume":"23","author":"Czernecki","year":"2008","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref29","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/brain\/awt067","article-title":"Parkinsonian apathy responds to dopaminergicstimulation of D2\/D3 receptors with piribedil","volume":"136","author":"Thobois","year":"2013","journal-title":"Brain"},{"key":"10.3233\/JPD-150535_ref30","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jocn.2008.12.010","article-title":"Dopamine dysregulation syndrome, impulse control disorders and punding after deep brainstimulation surgery for Parkinson\u2019s disease","volume":"16","author":"Lim","year":"2009","journal-title":"J Clin Neurosci"},{"key":"10.3233\/JPD-150535_ref31","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1073\/pnas.0908189107","article-title":"Reducing the desire for cocaine with subthalamic nucleus deep brain stimulation","volume":"107","author":"Rouaud","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-150535_ref32","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1460-9568.2007.05373.x","article-title":"Bilateral high-frequency stimulation of the subthalamicnucleus on attentional performance: Transient deleterious effectsand enhanced motivation in both intact and parkinsonian rats","volume":"25","author":"Baunez","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JPD-150535_ref33","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1523\/JNEUROSCI.4674-12.2013","article-title":"The organization of prefrontal-subthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration:Implications for Basal Ganglia models and deep brain stimulation","volume":"33","author":"Haynes","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-150535_ref34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/1531-8249(200005)47:5<655::AID-ANA16>3.0.CO;2-#","article-title":"Levodopa-induced dyskinesias in Parkinson\u2019sdisease: Is sensitization reversible?","volume":"47","author":"Bejjani","year":"2000","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-150535_ref35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neubiorev.2013.11.001","article-title":"Depression and impulsecontrol disorders in Parkinson\u2019s disease: Two sides of the samecoin?","volume":"38","author":"Vriend","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JPD-150535_ref36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neurol.2009.06.003","article-title":"[Assessment of hyper- and hypodopaminergic behaviors in Parkinson\u2019s disease].","volume":"165","author":"Ardouin","year":"2009","journal-title":"Rev Neurol (Paris)"},{"issue":"2","key":"10.3233\/JPD-150535_ref37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.26016","article-title":"Clinical spectrum of impulse control disorders in Parkinson\u2019s disease","volume":"30","author":"Weintraub","year":"2015","journal-title":"Mov Disord"},{"issue":"5","key":"10.3233\/JPD-150535_ref38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/mds.26223","article-title":"International validation of a behavioral scale in Parkinson\u2019s disease without dementia","volume":"30","author":"Rieu","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.expneurol.2012.04.025","article-title":"Dopamine pathway loss innucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys","volume":"236","author":"Brown","year":"2012","journal-title":"Exp Neurol"},{"key":"10.3233\/JPD-150535_ref40","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/mp.2013.3","article-title":"Loss of dopaminergic nigrostriatal neuronsaccounts for the motivational and affective deficits in Parkinson\u2019s disease","volume":"19","author":"Drui","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JPD-150535_ref41","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mds.25837","article-title":"Pramipexole reverses Parkinson\u2019s disease-related motivational deficits in rats","volume":"29","author":"Favier","year":"2014","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref42","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1038\/tp.2014.43","article-title":"Implication of dopamine D3 receptor activation inthe reversion of Parkinson\u2019s disease-related motivationaldeficits","volume":"4","author":"Carnicella","year":"2014","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JPD-150535_ref43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbr.2007.07.002","article-title":"Lesions ofdopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior inrats","volume":"184","author":"Winter","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.3233\/JPD-150535_ref44","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson\u2019s disease","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"key":"10.3233\/JPD-150535_ref45","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u2019s disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.3233\/JPD-150535_ref46","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1017\/S1461145714000236","article-title":"SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats","volume":"17","author":"Chen","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.3233\/JPD-150535_ref47","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fnbeh.2014.00290","article-title":"A mouse model of non-motor symptoms in Parkinson\u2019s disease: Focus onpharmacological interventions targeting affective dysfunctions","volume":"8","author":"Bonito-Oliva","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.3233\/JPD-150535_ref48","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson\u2019s disease: Loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"10.3233\/JPD-150535_ref49","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1212\/WNL.0000000000000941","article-title":"Preoperative factors of apathy in subthalamicstimulated Parkinson disease: A\u00a0PET study","volume":"83","author":"Robert","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JPD-150535_ref50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000345987","article-title":"Neuroimaging markers of motor and nonmotor features of Parkinson\u2019sdisease: An 18f fluorodeoxyglucose positron emission computed tomography study","volume":"35","author":"Huang","year":"2013","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JPD-150535_ref51","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fnagi.2014.00318","article-title":"Impulsive and compulsive behaviors in Parkinson\u2019s disease","volume":"6","author":"Zhang","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JPD-150535_ref52","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/brain\/aws078","article-title":"Subthalamic stimulation in Parkinson\u2019s disease: Restoring the balance of motivated behaviours","volume":"135","author":"Lhommee","year":"2012","journal-title":"Brain"},{"key":"10.3233\/JPD-150535_ref53","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/mds.26099","article-title":"Management of impulse control disorders in Parkinson\u2019s disease: Controversies and future approaches","volume":"30","author":"Samuel","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref54","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/WCO.0b013e32826fbc8f","article-title":"Medication-related impulsecontrol and repetitive behaviors in Parkinson\u2019s disease","volume":"20","author":"Voon","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"10.3233\/JPD-150535_ref55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mds.26068","article-title":"Linking neuroscience with modern concepts of impulse control disorders in Parkinson\u2019s disease","volume":"30","author":"Napier","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref56","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","article-title":"Prevalence of repetitive andreward-seeking behaviors in Parkinson disease","volume":"67","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JPD-150535_ref57","first-page":"589","article-title":"Impulse controldisorders in Parkinson disease: A\u00a0cross-sectional study of 3090patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol"},{"key":"10.3233\/JPD-150535_ref58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.26016","article-title":"Clinical spectrum of impulse control disorders in Parkinson\u2019sdisease","volume":"30","author":"Weintraub","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref59","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/ana.20822","article-title":"Compulsive drug use linked to sensitized ventral striatal dopamine transmission","volume":"59","author":"Evans","year":"2006","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-150535_ref60","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1212\/01.wnl.0000238401.76928.45","article-title":"Clinical features associated with impulse control disorders in Parkinson disease","volume":"67","author":"Pontone","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JPD-150535_ref61","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.parkreldis.2012.06.005","article-title":"Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson\u2019s disease","volume":"18","author":"Joutsa","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-150535_ref62","first-page":"93","article-title":"Dopamine and impulse control disorders in Parkinson\u2019s disease. S","volume":"(Suppl 2)","author":"Weintraub","year":"2008","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-150535_ref63","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00213-009-1697-y","article-title":"Impulsive choice and response in dopamine agonist-related impulse control behaviors","volume":"207","author":"Voon","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3233\/JPD-150535_ref64","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/mds.22472","article-title":"Cognitive dysfunctions and pathological gambling in patients with Parkinson\u2019s disease","volume":"24","author":"Santangelo","year":"2009","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref65","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1474-4422(03)00529-5","article-title":"Compulsive use of dopamine replacement therapy in Parkinson\u2019s disease:Reward systems gone awry?","volume":"2","author":"Lawrence","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-150535_ref66","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/01.wnl.0000184487.72289.f0","article-title":"Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease","volume":"65","author":"Evans","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JPD-150535_ref67","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.wco.0000137528.23126.41","article-title":"Dopamine dysregulation syndrome inParkinson\u2019s disease","volume":"17","author":"Evans","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"10.3233\/JPD-150535_ref68","first-page":"157","article-title":"Dopamine dysregulationsyndrome: An overview of its epidemiology, mechanisms andmanagement","volume":"23","author":"O\u2019Sullivan","year":"2009","journal-title":"CNS Drugs"},{"key":"10.3233\/JPD-150535_ref69","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00207454.2011.633722","article-title":"Addiction-likemanifestations and Parkinson\u2019s disease: A\u00a0large single center9-year experience","volume":"122","author":"Limotai","year":"2012","journal-title":"Int J Neurosci"},{"key":"10.3233\/JPD-150535_ref70","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","article-title":"Punding in Parkinson\u2019s disease: Itsrelation to the dopamine dysregulation syndrome","volume":"19","author":"Evans","year":"2004","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref71","first-page":"203","article-title":"Psychoses and the punding and choreiformsyndromes in addiction to central stimulant drugs","volume":"75","author":"Rylander","year":"1972","journal-title":"Psychiatr Neurol Neurochir"},{"key":"10.3233\/JPD-150535_ref72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0091-3057(81)80018-4","article-title":"Psychopathology induced by \u201cspeed drugs\u201d","volume":"(Suppl 1)","author":"Schiorring","year":"1981","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3233\/JPD-150535_ref73","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0006-3223(94)90636-X","article-title":"Punding on levodopa","volume":"36","author":"Friedman","year":"1994","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JPD-150535_ref74","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/mp.2009.95","article-title":"Insights into pathophysiology of punding reveal possible treatment strategies","volume":"15","author":"Fasano","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JPD-150535_ref75","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/mds.23061","article-title":"Punding in Parkinson\u2019s disease: The impact of patient\u2019s awareness on diagnosis","volume":"25","author":"Fasano","year":"2010","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref76","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/mds.21118","article-title":"Punding and dyskinesias","volume":"21","author":"Silveira-Moriyama","year":"2006","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref77","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.conb.2013.01.025","article-title":"Addiction: Failure of control over maladaptive incentive habits","volume":"23","author":"Belin","year":"2013","journal-title":"Curr Opin Neurobiol"},{"key":"10.3233\/JPD-150535_ref78","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrn1919","article-title":"The role of the basal ganglia in habit formation","volume":"7","author":"Yin","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JPD-150535_ref79","doi-asserted-by":"crossref","first-page":"10451","DOI":"10.1073\/pnas.181356498","article-title":"Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation","volume":"98","author":"Chartoff","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-150535_ref80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/187152706784111551","article-title":"The dopamine D3 receptor: A\u00a0therapeutic target forthe treatment of neuropsychiatric disorders","volume":"5","author":"Sokoloff","year":"2006","journal-title":"CNS NeurolDisord Drug Targets"},{"key":"10.3233\/JPD-150535_ref81","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00213-006-0578-x","article-title":"The debate over dopamine\u2019s role in reward: The case for incentive salience","volume":"191","author":"Berridge","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3233\/JPD-150535_ref82","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0006-8993(75)90233-4","article-title":"Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum","volume":"94","author":"Kelly","year":"1975","journal-title":"Brain Res"},{"key":"10.3233\/JPD-150535_ref83","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ana.23881","article-title":"Levodopa gains psychostimulant-like properties after nigral dopaminergic loss","volume":"74","author":"Engeln","year":"2013","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-150535_ref84","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/mds.21235","article-title":"Levodopa-induced hyperactivity in mice treated with1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"22","author":"Nicholas","year":"2007","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref85","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00003088-197601050-00001","article-title":"Clinical pharmacokinetics of levodopa in parkinson\u2019s disease","volume":"1","author":"Bianchine","year":"1976","journal-title":"Clin Pharmacokinet"},{"key":"10.3233\/JPD-150535_ref86","first-page":"17","article-title":"Pharmacokinetics and pharmacodynamics of levodopa","volume":"42","author":"Montgomery","year":"1992","journal-title":"Neurology"},{"key":"10.3233\/JPD-150535_ref87","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/brain\/awq301","article-title":"Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson\u2019s disease","volume":"134","author":"Rodriguez-Oroz","year":"2011","journal-title":"Brain"},{"key":"10.3233\/JPD-150535_ref88","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/brain\/awu195","article-title":"The modernpre-levodopa era of Parkinson\u2019s disease: Insights into motor complications from sub-Saharan Africa","volume":"137","author":"Cilia","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JPD-150535_ref89","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mds.21780","article-title":"Amantadine may reverse punding in Parkinson\u2019s disease\u2013observation in a patient","volume":"23","author":"Kashihara","year":"2008","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref90","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archneur.56.11.1383","article-title":"Amantadine for levodopa-induced dyskinesias: A\u00a01-yearfollow-up study","volume":"56","author":"Metman","year":"1999","journal-title":"Arch Neurol"},{"key":"10.3233\/JPD-150535_ref91","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22029","article-title":"Pathological gambling in Parkinson disease is reduced byamantadine","volume":"68","author":"Thomas","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-150535_ref92","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.22164","article-title":"Amantadine useassociated with impulse control disorders in Parkinson disease incross-sectional study","volume":"68","author":"Weintraub","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-150535_ref93","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2008.07.011","article-title":"Glutamatetransmission in addiction","volume":"(Suppl 1)","author":"Kalivas","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.3233\/JPD-150535_ref94","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/35079077","article-title":"Single cocaine exposure induces long-term potentiation in dopamine neurons","volume":"411","author":"Ungless","year":"2001","journal-title":"Nature"},{"key":"10.3233\/JPD-150535_ref95","doi-asserted-by":"crossref","first-page":"10187","DOI":"10.1523\/JNEUROSCI.2268-10.2010","article-title":"Long-lasting adaptations of the NR2B-containing NMDA receptors in the dorsomedial striatum play a crucial role in alcohol consumption and relapse","volume":"30","author":"Wang","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"10.3233\/JPD-150535_ref96","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/brain\/awp054","article-title":"Increased striatal dopamine release in Parkinsonian patients with pathological gambling: A\u00a0[11C] raclopride PET study","volume":"132","author":"Steeves","year":"2009","journal-title":"Brain"},{"key":"10.3233\/JPD-150535_ref97","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/brain\/awr003","article-title":"Cue-induced striatal dopamine release in Parkinson\u2019s disease-associated impulsive-compulsive behours","volume":"134","author":"O\u2019Sullivan","year":"2011","journal-title":"Brain"},{"key":"10.3233\/JPD-150535_ref98","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.nbd.2012.06.021","article-title":"Extrastriatal dopaminergic abnormalities of DA homeostasis inParkinson\u2019s patients with medication-induced pathologicalgambling: A\u00a0[11C] FLB-457 and PET study","volume":"48","author":"Ray","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JPD-150535_ref99","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1212\/01.wnl.0000242888.30755.5d","article-title":"Clinical correlates of levodopa-induced dopaminerelease in Parkinson disease: A\u00a0PET study","volume":"67","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JPD-150535_ref100","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.neuroimage.2012.02.006","article-title":"Mesolimbic dopamine release is linked to symptom severity in pathological gambling","volume":"60","author":"Joutsa","year":"2012","journal-title":"Neuroimage"},{"key":"10.3233\/JPD-150535_ref101","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/WNL.0b013e3181fc27fa","article-title":"Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD","volume":"75","author":"van Eimeren","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JPD-150535_ref102","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/jnnp-2013-305395","article-title":"Impulse control disorders in Parkinson\u2019s disease: Decreased striatal dopamine transporter levels","volume":"85","author":"Voon","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-150535_ref103","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mds.25886","article-title":"Reduced dopamine transporter binding predates impulse control disordersin Parkinson\u2019s disease","volume":"29","author":"Vriend","year":"2014","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150535_ref104","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nbd.2010.03.013","article-title":"Reduced dopamine transporter density in the ventral striatum of patients with Parkinson\u2019s disease and pathological gambling","volume":"39","author":"Cilia","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JPD-150535_ref105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.parkreldis.2011.10.005","article-title":"Apathy and impulse control disorders in Parkinson\u2019s disease: A\u00a0direct comparison","volume":"18","author":"Leroi","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-150535_ref106","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/jnp.12013","article-title":"Impulsivity and apathy in Parkinson\u2019s disease","volume":"7","author":"Sinha","year":"2013","journal-title":"J Neuropsychol"},{"key":"10.3233\/JPD-150535_ref107","first-page":"81","article-title":"Impulse control disorders with the use ofdopaminergic agents in restless legs syndrome: A\u00a0case-controlstudy","volume":"33","author":"Cornelius","year":"2010","journal-title":"Sleep"}],"container-title":["Journal of Parkinson's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JPD-150535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:44:00Z","timestamp":1777610640000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JPD-150535"}},"subtitle":[],"editor":[{"given":"Amos D.","family":"Korczyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Heinz","family":"Reichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"K. Ray","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,14]]},"references-count":107,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jpd-150535","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,14]]}}}